Nasdaq

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...
Nasdaq

ApiJect Announces Investment by Royalty Pharma and Jefferies

$111 Million Equity Investment Round to Support Continued Development and Deployment of ApiJect's Proprietary High-Volume Manufacturing Platform for Single-Dose Prefilled Injection Devices. This ...
FiercePharma

Syringe maker ApiJect reels in $111M in private investment round

ApiJect, which was founded in 2015 to make safe, cheap prefilled syringes for developing countries, hauled in $111 million in a private round of investment. Funds from the round, which was led by ...
GEN

From Columbia to the World: Ritedose Redefines Aseptic Manufacturing

Since its founding in 1995, The Ritedose Corporation has evolved from a small-scale operation into one of the world’s leading specialists in Blow-Fill-Seal (BFS) technology, a platform increasingly ...
Mena FN

France Blow Fill Seal Technology Market Driven By Biologics Demand, Led By Unither Pharmaceuticals, Catalent, Rommelag

(MENAFN- EIN Presswire) EINPresswire/ -- According to Fact's latest analysis, the France Blow Fill Seal technology market is gaining strong momentum, supported by the country's advanced pharmaceutical ...